Beijing Beilu Pharmaceutical Co Ltd Class A

Beijing Beilu Pharmaceutical Co Ltd Class AChina

€0.87
Dividend Yield (FWD)
1.40%
Annual Payout (FWD)
CN¥0.07
Dividend Growth Rate (CAGR)
#.##%
Ex-DatePay DateAmountChange
CN¥0.07
0%
CN¥0.07
0%
CN¥0.07
16.67%
CN¥0.07
16.67%
CSV Export

Beijing Beilu Pharmaceutical Co Ltd Class A pays a dividend yield (FWD) of 1.40%.

ISIN
WKN
-
Symbol / Exchange
/ XSHE
Value
€0.87
Dividend frequency
annually
Security Type
Equity
Sector

Health Care

Country
China

China

Dividend Currency
Chinese Yuan
Resources

Frequently Asked Questions about Beijing Beilu Pharmaceutical Co Ltd Class A

Within the last 12 months, Beijing Beilu Pharmaceutical Co Ltd Class A paid a dividend of CN¥0.00. For the next 12 months, Beijing Beilu Pharmaceutical Co Ltd Class A is expected to pay a dividend of CN¥0.07. This corresponds to a dividend yield of approximately 1.40%.
The dividend yield of Beijing Beilu Pharmaceutical Co Ltd Class A is currently 1.40%.
Beijing Beilu Pharmaceutical Co Ltd Class A pays annually dividends. Payout is in May.
The next dividend for Beijing Beilu Pharmaceutical Co Ltd Class A is expected in May.
Within the last 10 years, Beijing Beilu Pharmaceutical Co Ltd Class A has paid dividends in 9 of them.
Dividends of CN¥0.07 are expected for the next 12 months. This corresponds to a dividend yield of 1.40%.
Beijing Beilu Pharmaceutical Co Ltd Class A is assigned to the sector "Health Care".
The last stock split of Beijing Beilu Pharmaceutical Co Ltd Class A was on 4 September 2018 in the ratio 2:1.
To receive the last dividend of Beijing Beilu Pharmaceutical Co Ltd Class A on 25 May 2023 in the amount of CN¥0.07 you had to have the stock in your portfolio before the ex-day on 25 May 2023.
The last dividend was paid on 25 May 2023.
In 2022, dividends of CN¥0.07 were paid by Beijing Beilu Pharmaceutical Co Ltd Class A.
Dividends from Beijing Beilu Pharmaceutical Co Ltd Class A are paid in Chinese Yuan.
The headquarters of Beijing Beilu Pharmaceutical Co Ltd Class A is located in China.